We're making headlines in advancing critical care http://www.ikaria.com/media/ikaria-news.html April 16, 2013 http://www.ikaria.com/media/news/press_2013-Apr16-BIO.pdf IKARIA TO PRESENT AT 2013 BIO BUSINESS FORUM AND INTERNATIONAL CONVENTION November 13, 2012 http://www.ikaria.com/media/news/Press_2012-11-13-DSIR-Cleared-Compatibility.pdf FDA CLEARS INOMAX DSIR TO CONNECT WITH HOSPITAL HEALTH INFORMATION SYSTEMS August 7, 2012 http://www.ikaria.com/media/news/press_2012-Aug7-Wedbush-Securities.pdf IKARIA TO PRESENT AT WEDBUSH SECURITIES 2012 LIFE SCIENCES MANAGEMENT ACCESS CONFERENCE June 12, 2012 http://www.ikaria.com/media/news/press_2012_June12-BIO.pdf IKARIA TO PRESENT AT 2012 BIO INTERNATIONAL CONVENTION April 23, 2012 http://www.ikaria.com/media/news/press_2012-Apr23-Lucassin.pdf LUCASSIN APPROVED IN AUSTRALIA February 27, 2012 http://www.ikaria.com/media/news/press_2012_02_27_BPD-LPI.pdf IKARIA COMPLETES PATIENT ENROLLMENT IN PIVOTAL PHASE III TRIAL FOR BRONCHOPULMONARY DYSPLASIA April 11, 2012 http://www.ikaria.com/media/news/Press_2012_04_11_Stauffer-Appointment.pdf IKARIA APPOINTS CHIEF MEDICAL OFFICER March 21, 2012 http://www.ikaria.com/media/news/press_2012_03_21_FDA.pdf FDA CLEARS EXPANDED COMPATIBILITY FOR INOMAX DRUG-DELIVERY SYSTEMS February 6, 2012 http://www.ikaria.com/media/news/press_2012-Feb6-CEO-Investor.pdf IKARIA TO PRESENT AT 14TH ANNUAL BIO CEO January 23, 2012 http://www.ikaria.com/media/news/press_2012-Jan23-Orphan.pdf FDA GRANTS ORPHAN DRUG DESIGNATION TO IKARIA FOR USE OF INHALED NITRIC OXIDE IN PULMONARY ARTERIAL HYPERTENSION January 4, 2012 http://www.ikaria.com/media/news/Press_2012_4_Jan_Biotech_Showcase.pdf IKARIA TO PRESENT AT BIOTECH SHOWCASE™ 2012 January 3, 2012 http://www.ikaria.com/media/news/press_2012-Jan3-BCM-Trial-Initiation.pdf IKARIA COMMENCES GLOBAL REGISTRATION TRIAL FOR BIOABSORBABLE CARDIAC MATRIX December 22, 2011 http://www.ikaria.com/media/news/press_2011-Dec22-DS-Recall-2-Class-I.pdf IKARIA ISSUES NOTICE OF COMPLETED REMEDIATION FOR INOMAX DS DRUG-DELIVERY SYSTEM November 8, 2011 http://www.ikaria.com/media/news/press_2011_Nov8-karia-Lazard-Conference.pdf IKARIA TO PRESENT AT 2011 LAZARD CAPITAL MARKETS HEALTHCARE CONFERENCE October 18, 2011 http://www.ikaria.com/media/news/press_2011-Oct18-BIO.pdf IKARIA TO PRESENT AT 2011 BIO INVESTOR FORUM October 11, 2011 http://www.ikaria.com/media/news/press_2011_10_11-CFO.pdf IKARIA NAMES NEW CHIEF FINANCIAL OFFICER September 22, 2011 http://www.ikaria.com/media/news/press_2011-Sept22-Tasse.pdf IKARIA CEO DANIEL TASSÉ ELECTED TO PhRMA BOARD OF DIRECTORS August 31, 2011 http://www.ikaria.com/media/news/press_2011-Aug31-Stifel-Nicolaus.pdf IKARIA TO PRESENT AT STIFEL NICOLAUS 2011 HEALTHCARE CONFERENCE August 9, 2011 http://www.ikaria.com/media/news/press_2011-Aug9-Wedbush.pdf IKARIA TO PRESENT AT 2011 WEDBUSH LIFE SCIENCES MANAGEMENT ACCESS CONFERENCE August 1, 2011 http://www.ikaria.com/media/news/press_2011_august_compatability.pdf FDA CLEARS EXPANDED COMPATIBILITY FOR INOMAX DRUG-DELIVERY SYSTEMS June 28, 2011 http://www.ikaria.com/media/news/press_2011_June28_ceo_tasse.pdf IKARIA CEO DANIEL TASSÉ ELECTED TO HEALTH SECTION OF BIO'S BOARD OF DIRECTORS June 21, 2011 http://www.ikaria.com/media/news/press_2011_June_21_BIO.pdf IKARIA TO PRESENT AT 2011 BIO BUSINESS FORUM AND INTERNATIONAL CONVENTION April 11, 2011 http://www.ikaria.com/media/news/press_2011-Apr11-launch.pdf IKARIA LAUNCHES NEXT-GENERATION DRUG-DELIVERY SYSTEM March 23, 2011 http://www.ikaria.com/media/news/press_2011_Mar_Australia.pdf IKARIA INTRODUCES NEXT-GENERATION INOMAX DRUG-DELIVERY SYSTEM IN AUSTRALIA March 2, 2011 http://www.ikaria.com/media/news/press_2011_Mar2_Cowen.pdf IKARIA TO PRESENT AT 31st ANNUAL COWEN AND COMPANY HEALTHCARE CONFERENCE February 22, 2011 http://www.ikaria.com/media/news/press_2011_Feb22_DSIRLaunch_inCanada.pdf IKARIA INTRODUCES NEXT-GENERATION DRUG-DELIVERY SYSTEM IN CANADA January 5, 2011 http://www.ikaria.com/media/news/press_2011_Jan5-Exclusivity.pdf FDA EXTENDS MARKETING EXCLUSIVITY FOR INOMAX November 30, 2010 http://www.ikaria.com/media/news/press_2010_Nov30-Lucassin.pdf IKARIA BEGINS ENROLLMENT OF PIVOTAL TRIAL FOR LUCASSIN August 9, 2010 http://www.ikaria.com/media/news/press_2010_Aug9-DS-Recall.pdf IKARIA RECALLS INOMAX DS DRUG-DELIVERY SYSTEM July 15, 2010 http://www.ikaria.com/media/news/press_2010_july15_CSO.pdf IKARIA NAMES CHIEF SCIENCE OFFICER July 8, 2010 http://www.ikaria.com/media/news/press_2010_July8_CFO.pdf IKARIA NAMES NEW CHIEF FINANCIAL OFFICER June 8, 2010 http://www.ikaria.com/media/news/press_2010_June8_Nichol-Appointment.pdf IKARIA APPOINTS CHIEF MEDICAL OFFICER June 1, 2010 http://www.ikaria.com/media/news/press_2010_1_June_GreeneAppointment.pdf IKARIA NAMES NEW HEAD OF RESEARCH April 14, 2010 http://www.ikaria.com/media/news/press_2010_apr14_Pien.pdf IKARIA ANNOUNCES ELECTION OF HOWARD H. PIEN TO BOARD OF DIRECTORS March 30, 2010 http://www.ikaria.com/media/news/press_2010_mar30_LUCASSIN.pdf IKARIA ACQUIRES NEW DRUG APPLICATION FOR LUCASSIN March 24, 2010 http://www.ikaria.com/media/news/press_2010_Mar24_CNMC.pdf $2.5 MILLION GIFT AIMS TO HELP CHILDREN SURVIVE AND THRIVE October 21, 2009 http://www.ikaria.com/media/news/press_2009_10_21_Award.pdf IKARIA RECEIVES AWARD FOR EXCELLENCE BY NEW JERSEY BUSINESS October 19, 2009 http://www.ikaria.com/media/news/press_2009_101609.pdf IKARIA NAMES NEW CHAIRMAN August 10, 2009 http://www.ikaria.com/media/news/press_2009_aug10_Fibrex.pdf IKARIA TO IN-LICENSE WORLDWIDE RIGHTS TO INVESTIGATIONAL PORTFOLIO FROM FIBREX MEDICAL July 6, 2009 http://www.ikaria.com/media/news/press_2009_July6.pdf IKARIA TO IN-LICENSE BIOLINERx'S BL-1040 Jun 12, 2009 http://www.ikaria.com/media/news/press_2009_12_jun_FDA_Accepts.pdf FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN Jan 8, 2009 http://www.ikaria.com/media/news/press_2009_8_jan_JPMorganHealthcare.pdf IKARIA TO PRESENT AT 27th ANNUAL JPMORGAN HEALTHCARE CONFERENCE Nov 21, 2008 http://www.ikaria.com/media/news/Press_2008_11_Nov_NJTCAward.pdf IKARIA NAMED PRIVATE COMPANY OF THE YEAR BY NEW JERSEY TECHNOLOGY COUNCIL Oct 25, 2008 http://www.ikaria.com/media/news/press_2008_25_Oct_INOT_27_Phase_3.pdf INHALED NITRIC OXIDE DATA PRESENTED AT EUROPEAN ACADEMY OF PEDIATRICS MEETING Oct 2, 2008 http://www.ikaria.com/media/news/press_2008_2_Oct_SVP_Engineering_Ops.pdf IKARIA STRENGTHENS EXECUTIVE LEADERSHIP TEAM Sept. 2, 2008 http://www.ikaria.com/media/news/press_2008_2_sept_LUCASSIN_Acquisition.pdf IKARIA ACQUIRES NORTH AMERICAN RIGHTS TO LUCASSIN FROM ORPHAN THERAPEUTICS Aug. 25, 2008 http://www.ikaria.com/media/news/press_2008_Aug_25_SVP_Appointments.pdf IKARIA STRENGTHENS COMMERCIAL OPERATIONS AND HUMAN RESOURCES LEADERSHIP July 28, 2008 http://www.ikaria.com/media/news/press_2008_28_july_Covox.pdf IKARIA RECEIVES FDA ORPHAN DRUG DESIGNATION FOR INHALED CARBON MONOXIDE FOR DELAYED GRAFT FUNCTION IN SOLID ORGAN TRANSPLANTS July 21, 2008 http://www.ikaria.com/media/news/press_2008_21_july_INOflo_Japan_Approval.pdf IKARIA'S INOFLO (NITRIC OXIDE) FOR INHALATION APPROVED IN JAPAN July 1, 2008 http://www.ikaria.com/media/news/press_2008_1_July_RD_Appointments.pdf IKARIA STRENGTHENS RESEARCH June 24, 2008 http://www.ikaria.com/media/news/press_2008_24_June_RD_Appointment.pdf IKARIA INTRODUCES DR. MICHAEL COOREMAN AS VICE PRESIDENT OF TRANSLATIONAL MEDICINE June 18, 2008 http://www.ikaria.com/media/news/press_release_2008_June_18_INOflo_Japan.pdf IKARIAS INOFLO (NITRIC OXIDE) FOR INHALATION TO BE OFFICIALLY APPROVED IN JAPAN May 19, 2008 http://www.ikaria.com/media/news/press_2008_May_19_IK-1001_Dosing.pdf IKARIA COMPLETES DOSING OF PHASE 1A CLINICAL STUDY FOR IK-1001 Jan. 22, 2008 http://www.ikaria.com/media/news/Press_2008_Jan_22_Zoth.pdf LOTA ZOTH ELECTED TO IKARIA BOARD AND NAMED AUDIT COMMITTEE CHAIR Jan. 17, 2008 http://www.ikaria.com/media/news/press_2008_Jan_17_Zenith_Award.pdf IKARIA WINS SECOND CONSECUTIVE AARC ZENITH AWARD Jan. 9, 2008 http://www.ikaria.com/media/news/Press_2008_9_Jan.pdf IKARIA APPOINTS DANIEL TASSÉ AS PRESIDENT AND CHIEF EXECUTIVE OFFICER Jan. 3, 2008 http://www.ikaria.com/media/news/press_2008_3_jan_JPMorganHealthcare.pdf IKARIA TO PRESENT AT 26th ANNUAL JPMORGAN HEALTHCARE CONFERENCE November 27, 2007 http://www.ikaria.com/media/news/press_2007_Nov_27_Australia.pdf IKARIA'S INOMAX (NITRIC OXIDE) FOR INHALATION APPROVED IN AUSTRALIA October 1, 2007 http://www.ikaria.com/media/news/press_2007_1_October_Rosskamp.pdf IKARIA NAMES EXECUTIVE VICE PRESIDENT OF RESEARCH AND DEVELOPMENT September, 26, 2007 http://www.ikaria.com/media/news/press_release_2007_26_September_MacArthur.pdf IKARIA FOUNDING SCIENTIST NAMED 2007 MACARTHUR FELLOW September 25, 2007 http://www.ikaria.com/media/news/Press_2007_05_september_H2S.pdf NEW STUDY SHOWS PROMISE FOR HYDROGEN SULFIDE IN REDUCING HEART-ATTACK DAMAGE, IKARIA ANNOUNCES July 23, 2007 http://www.ikaria.com/media/news/press_2007_23_july.pdf MATTHEW BENNETT JOINS IKARIA AS VICE PRESIDENT AND GENERAL COUNSEL May 2, 2007 http://www.ikaria.com/media/news/press_2007_may.pdf DAVID SHAW TO SERVE AS PRESIDENT OF IKARIA AND INO THERAPEUTICS March 28, 2007 http://www.ikaria.com/media/news/press_2007_march.pdf IKARIA AND INVESTOR GROUP CLOSE TRANSACTION TO ACQUIRE INO THERAPEUTICS FROM LINDE IN $670 MILLION CASH AND STOCK MERGER, CREATING A WORLD LEADER IN CRITICAL CARE THERAPEUTICS February 25, 2007 http://www.ikaria.com/media/news/press_Feb25_2007OHSU.pdf IKARIA ANNOUNCES IN-LICENSING OF "THYRONAMINE TECHNOLOGY" FROM THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO AND OREGON HEALTH December, 2006 http://www.ikaria.com/media/news/press_2006_december.pdf INO THERAPEUTICS WINS ZENITH AWARD